Revium Rx (RVRC) Long-Term Deferred Tax (2024 - 2025)
Revium Rx (RVRC) reported Long-Term Deferred Tax of $9.2 million for Q4 2025, up 66.39% on a YoY basis from $5.5 million in Q4 2024, and up 66.39% sequentially from $5.5 million in Q4 2024.
Revium Rx (RVRC) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
Revium Rx (RVRC) has 2 years of Long-Term Deferred Tax data on file, last reported at $9.2 million in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Deferred Tax rose 66.39% year-over-year to $9.2 million; the trailing twelve-month figure through Dec 2025 stood at $9.2 million (up 66.39% YoY), and the FY2025 full-year result was $9.2 million, up 66.39% from the prior year.
- Long-Term Deferred Tax improved to $9.2 million in Q4 2025, from $5.5 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $9.2 million in Q4 2025 to a low of $5.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 31.74 Bn | 24.42 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.63 Bn | 13.73 Bn | 482.22 Mn |
| 3 | Healthequity | 8.31 Bn | 8.05 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.95 Bn | 5.64 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.79 Bn | 5.26 Bn | 106.18 Mn |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn |
| 8 | Doximity | 3.96 Bn | 3.22 Bn | 125.97 Mn |
| 9 | Privia Health | 3.17 Bn | 2.75 Bn | - |
| 10 | Revium Rx | 101.42 Mn | 98.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.22 Mn |
| Dec 31, 2024 | 5.54 Mn |